Gregory T. Hebrank

LaunchCyte LLC (LaunchCyte) is a venture capital firm founded in 2000 by Tom A.Petzinger and Barbara Bailey Carryer. The firm is headquartered in Pittsburgh, Pennsylvania.

Reaction Biology Corp. specializes in kinase and epigenetic HTS and profiling services. It offers radiolabeled biochemical assays available for multiple enzyme classes including: Kinase Assays, HMT Assays, and HDAC Assays. Its products include Methyltransferase, IDH proteins, Apoptosis, DNA Demethylation, Apoptosis and NQOs. The company was founded by Scott L. Diamond in 2001 and is headquartered in Malvern, PA.

Veran Medical Technologies, Inc. designs, develops, and markets soft tissue equipment. The firm's main focus is assisting physicians in the early diagnosis and treatment of lung cancer. The company was founded by Ben Heavrin, Bruce Lynskey, Jerome R. Edwards, and Evan Austill, Jr. in 2005 and is headquartered in St. Louis, MO.

Nova Chemicals, Inc. produces plastics and chemicals. Its products include styrenic, olefin, and polyolefin materials to the packaging, industrial, and consumer industries. The company was founded in November 29, 1999 and is headquartered in Moon Township, PA.

Advanced Catheter Therapies, Inc. operates as an early stage research and development medical device company. It develops a catheter technologies targeting vascular disease including thrombosis, inflammation, occlusions and restenosis. The company was founded by C. Rex Teeslink, Paul J. Fitzpatrick, and Dirk V. Hoyns in 2008 and is headquartered in Chattanooga, TN.

Aerial BioPharma LLC operates as a biopharmaceutical company. It focuses on developing biologics and small molecules for conditions that are affected by processes in the Central Nervous System. The company was founded by Moise A. Khayrallah, stephen E. Butts and Gary Bream in January 2011 and is headquartered in Morrisville, NC.

EnviCor Enterprises LLC designs and manufactures plastic molders. It offers custom molders for the manufacture of paddle boards, barrels, plastic containers, septic equipment and water tanks. The company was founded by G. Steve Arnold in 2006 and is headquartered in Smithfield, NC.

SCILEX Pharmaceuticals, Inc. engages in the development and commercialization of pharmaceutical products. It acquires late-stage clinical development and sales and marketing of generic and branded generic products. Its product includes ZTlido. The company was founded by Anthony P. Mack and William Pedranti in 2011 and is headquartered in Berwyn, PA.

Life Sciences Pennsylvania (LSPA) is a trade association that represents various entities in the life sciences industry, including biotechnology, medical device, diagnostic, pharmaceutical, research, and investment companies, as well as service providers. The non-profit company is based in Wayne, PA and has subsidiaries in the United States. The organization unifies innovators in the state to make Pennsylvania a leader in the life sciences industry. Founded in 1989, LSPA aims to create a business and public policy environment that encourages and incentivizes the diverse life sciences economy in Pennsylvania. Christopher P. Molineaux has been the CEO of the company since 2009.

Part of Merck & Co., Inc., Merck Research Laboratories Massachusetts LLC is a pharmaceutical company that provides free medicines and adult vaccines to qualified patients through their Merck Patient Assistance Program. The company is based in Boston, MA and is a part of Merck & Co., Inc. and its affiliates. The company also offers information about insurance coverage and financial assistance options for eligible patients. The company conducts clinical trials and provides medical information covering thousands of topics in all fields of medicine through their Merck Manuals. Additionally, they report on their commitment to operating responsibly to benefit society through their corporate responsibility program, which includes their environmental, social, and governance (ESG) report. Merck for Mothers is an initiative to create a world where no woman has to die giving life.

Part of Pediatrix Medical Group, Inc., Regional Obstetric Consultants provides healthcare services. The company is based in Jacksonville, FL. The company was founded by C. David Adair. Regional Obstetric Consultants was acquired by Pediatrix Medical Group, Inc. on May 26, 2009.

Glenveigh Medical LLC develops drugs and devices to prevent the causes of premature births. Its products include Ebb, a tamponade solution for postpartum hemorrhage; Jetty, a solution for episiotomy and vaginal laceration repair; and Beacon, a fetal monitor. The company was founded by C. David Adair in 2004 and is headquartered in Chattanooga, TN.

Part of Royal Bank of Canada, RBC Capital Markets, Inc. provides investment advice. The company is based in Albany, NY.

Oakwood Laboratories LLC operates as a technology-based specialty pharmaceutical company. The firm focuses on hard-to-develop generic and quasi-generic, sustained-release, and small molecule injectables. It develops and owns a patented microsphere-based drug delivery platform under Chroniject trademark. The company was founded by Edward C. Smith and Mark T. Smith in 1997 and is headquartered in Oakwood Village, OH.

The Keck School of Medicine of USC is a place of dynamic activity in patient care, scientific discovery, medical and bioscience education, and community service. Their faculty, staff, students, residents, alumni, donors and friends are committed to excellence. Together they are poised to lead medicine in the 21st Century for the benefit of humankind. This is an exciting time of great transformation as they endeavor to create a truly stellar academic medical center at USC.

Solas Bioventures (mayfield) LLC is a venture capital firm founded in 2012 by David Adair and Mark Hackett JD. The firm is headquartered in Chattanooga, Tennessee.

Arrivo Management LLC is a biopharmaceutical company. It develops biologics and small molecules to improve patient lives. The company was founded by Steve Butts, Bill Wofford, Michael Ackermann and Jed Black on July 9, 2015 and is headquartered in Morrisville, NC.

The Parkinson's Foundation provides scientific research for diseases. The company was founded in 1987 and is headquartered in New York, NY.

ReWind Therapeutics NV is a biotech company based in Leuven, Belgium that develops first-in-class remyelinating therapies for myelin-related diseases. The Belgian company's aim is to bring these therapies into fast-track clinical development. Myelin-related diseases, such as multiple sclerosis, are those where the myelin sheath surrounding nerves is damaged, leading to deficient nerve transmission that may affect multiple functions, including sensation, cognition, and movement, among others. ReWind Therapeutics develops first-in-class therapeutics designed to re-initiate the process of remyelination in patients suffering from major debilitating diseases such as multiple sclerosis, optic neuritis, or nerve injuries. The company's team has extensive R&D expertise and has built a strong patent estate for developing novel remyelination therapeutics. The company was founded in 2017 by Ku Leuven's Centre for Drug Design and Discovery (CD3) and Axxam S.p.A. The CEO of the company since 2021 is Anja Harmeier.

Scilex, Inc. engages in the acquisition, development, and commercialization of non-opioid pain management products for the treatment of acute and chronic pain. The company is headquartered in Paolo Alto, CA.

QuatroBio LLC engages in drug development services. The company was founded by Moise A. Khayrallah on September 4, 2014 and is headquartered in Morrisville, NC.

Full Spectrum Genetics, Inc. is an American company. The private company is located in the US.

Areteia Therapeutics, Inc. is a clinical stage biotechnology company that focuses on developing and delivering novel inflammation and immunology therapies for respiratory patients. The company is based in Short Hills, NJ, and the CEO of the company is Jorge Bartolome. The company's initial focus is on developing the first potential oral drug for eosinophilic asthma, with its lead drug candidate being dexpramipexole, a first-in-class oral eosinophil maturation inhibitor. Areteia was created by Population Health Partners and Knopp Biosciences, and a syndicate of leading life sciences and strategic investors has committed to investing up to $350 million in series A financing to establish Areteia and advance dexpramipexole through phase III clinical trials.